ISPOR INITIATIVE ADVANCES HIGH-QUALITY VALUE ASSESSMENT FRAMEWORKS FOR HEALTH CARE INTERVENTIONS

Published Feb 26, 2017

Value in Health Themed Issue Examines the Development and Dissemination of High-Quality, Unbiased Frameworks

  Princeton, NJ—February 27, 2017— The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of a special theme issue of its flagship journal, Value in Health, devoted to methodological, process, and ethical considerations of value assessment frameworks. Published in the February 2017 issue, this special collection of 22 articles addresses approaches and methods to support the definition and use of high-quality frameworks. The special theme issue was developed in conjunction with the ISPOR Initiative on US Value Assessment Frameworks. The guest editors are Jalpa Doshi, PhD, Director of the Economic Evaluations Unit of the Center for Evidence-Based Practice at the University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA, and Richard J. Willke, PhD, Chief Science Officer at ISPOR, Lawrenceville, NJ, USA. Assessing value in health care is not a new concept. Nevertheless, the discussion about using value assessment frameworks to support payers, physicians, and patients in health care decision making has increased dramatically in the United States. “We believe the reports in this themed issue will broaden our thinking on the various perspectives and challenges associated with value assessments,” noted Dr. Doshi. To provide a general sense of the breadth and depth of the topics addressed in this issue, the articles are grouped in 6 distinct sections: - Evaluating Existing Value Frameworks. The first section includes 3 papers that evaluate existing value frameworks on a variety of metrics, highlighting their strengths and weaknesses. - Addressing Gaps in Cost-Effectiveness Analysis. The second section comprises 4 papers that address a diverse set of shortcomings of traditional cost-effectiveness analyses. - Value and Affordability. The third section contains 3 papers that provide perspectives on how affordability might be judged. - Incorporating Multiple Dimensions of Value in Decision-Making. This section includes 4 papers that describe value-framework alternatives that may be particularly responsive to varying stakeholder preferences and provide a basis for decision-making. - Alternative Approaches for Value-Based Assessments. The fifth section consists of 3 papers that describe alternative frameworks for assessing the value of health interventions from the payer perspective, including some that have been implemented in health care systems outside the United States. - Patient and Other Stakeholder Perspectives on Value. The final section includes 5 commentaries that represent patient, shared-decision making, regulatory, and multi-stakeholder perspectives.   This themed issue presents a broad array of perspectives on value assessments and provides an overview of key issues with existing approaches to inform real-world decision making. “We hope that this themed issue—together with future findings and publications from ISPOR’s Initiative on Value Assessment Frameworks—will ultimately contribute to solutions for supporting robust value-based decision making in health care,” said Dr. Willke.

###

 

Related Stories

ISPOR Global Panel Proposes New Structure to Improve Definitions of Digital Health Interventions

Apr 9, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the publication of a report from the ISPOR Digital Health Special Interest Group that proposes a new framework to help standardize and clarify definitions used for digital health interventions. The report, “The PICOTS-ComTeC Framework for Defining Digital Health Interventions: An ISPOR Special Interest Group Report” was published in the April 2024 issue of Value in Health.

ISPOR International Panel Calls for Consensus on Medication Adherence Measures

Feb 26, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the publication of a new report from the ISPOR Medication Adherence and Persistence Special Interest Group revealing significant inconsistencies in how researchers measure the effectiveness of interventions aimed at improving medication adherence. The report, “A Systematic Review of Outcomes for Assessment of Medication Adherence Enhancing Interventions: An ISPOR Special Interest Group Report” was published in the February 2024 issue of Value in Health.

Global Experts Highlight Concerns With Implementation of IRA-Mandated Medicare Drug Price Negotiation Program

Dec 5, 2023

Value in Health announced the publication of 2 new commentaries by leading experts in health economics and outcomes research, both of which raise important questions as the Centers for Medicare & Medicaid Services move forward to implement the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×